NCT06224309
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,651 public trials
849 recruiting studies
Lymphoma trial results
Completed
CAR-T for R/R B-NHL
NCT03196830
- Conditions
- CAR - T CD19/CD20/CD22/CD30, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- the First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT04923789
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Completed
A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
NCT05020652
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Guangdong Provincial Peoples Hospital Guangzhou, Guangdong, China
- West China School of Medicine / West China Hospital, Sichuan University Chengdu, Sichuan, China
- Institute of Hematology & Blood Diseases Hostpital, Chinese Academy of medical sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
NCT02883049
- Conditions
- B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Burkitt Lymphoma, +18 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
Completed
A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma
NCT04539444
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT05322330
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT02651662
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
- Dana Farber/Harvard Cancer Center - PO box 849168 Boston, Massachusetts, United States
- Harvard Medical School - Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Cancer & Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
NCT04600804
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ematologia Ospedale Vito Fazzi Lecce, Apulia, Italy
- U.O.C Ematologia e Trapianto A.O. C. Panico Tricase, Apulia, Italy
- U.O.Ematologia Ospedale Guglielmo da Saliceto Piacenza, Emilia-Romagna, Italy
- Ematologia Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova Reggio Emilia, Emilia-Romagna, Italy
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States